A detailed history of American Century Companies Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 50,429 shares of STTK stock, worth $57,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,429
Previous 47,367 6.46%
Holding current value
$57,993
Previous $182,000 3.85%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.0 - $4.85 $9,186 - $14,850
3,062 Added 6.46%
50,429 $175,000
Q2 2024

Aug 07, 2024

BUY
$3.56 - $11.18 $34,204 - $107,417
9,608 Added 25.45%
47,367 $182,000
Q1 2024

May 14, 2024

BUY
$7.37 - $10.09 $278,283 - $380,988
37,759 New
37,759 $337,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $48.7M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.